BENSALEM, Pa., Feb. 12, 2025 /PRNewswire/ — The Law Offices of Howard G. Smith has announced that investors who faced significant losses now have a chance to take the lead in a securities fraud class action lawsuit against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) APLT.
ARE YOU AN INVESTOR WHO HAS EXPERIENCED A LOSS IN APPLIED THERAPEUTICS, INC. (APLT)? CONTACT THE LAW OFFICES OF HOWARD G. SMITH BY FEBRUARY 18, 2025 (LEAD PLAINTIFF DEADLINE) TO JOIN THE LAWSUIT.
To explore your legal options, reach out to the Law Offices of Howard G. Smith via email at [email protected], by phone at (215) 638-4847, or visit our website at www.howardsmithlaw.com.
What Are the Allegations in the Lawsuit?
The lawsuit claims that from January 3, 2024 to December 2, 2024, the defendants failed to inform investors that: (1) Applied Therapeutics was not following trial protocols and good clinical practices, raising the risk that the FDA would reject its trial data during the New Drug Application (NDA) process; and (2) therefore, the company’s positive statements regarding its business and prospects were either misleading or unfounded throughout that period.
Get in Touch to Learn More:
If you would like more details about this class action or have questions about your rights, please contact:
Howard G. Smith, Esq.,
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Call us at: (215) 638-4847
Email: [email protected],
Visit: www.howardsmithlaw.com.
To participate in the class action, you do not have to take action right now; you can choose to hire your own attorney or remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions based on applicable laws and ethical guidelines.
Contact Us for More Information:
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
[email protected]
www.howardsmithlaw.com
View original content: here.
SOURCE Law Offices of Howard G. Smith
Market News and Data brought to you by Benzinga APIs
